Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Reston › NPI 1053363853
Hospital

Reston Hospital Center LLC

Reston Hospital Center LLC was paid $14.91M by Medicaid between Jan 2018 and Dec 2024, across 156 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.

33Billing provider infoRESTON HOSPITAL CENTER LLC
RESTON, VA 20190
33aNPI1053363853assigned 05/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.91M
24GClaims395,191
24DCodes billed156
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Virginia

Rank by total paid#40 of 80
Median peer was paid$14.69M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201839,853$927K
201961,520$1.61M
202046,235$1.52M
202156,015$1.83M
202263,375$2.53M
202371,525$3.35M
2024incomplete56,668$3.15M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 28% 22,939 19,494 $4.13M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 25% 22,015 18,042 $3.73M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.6% 6,695 5,824 $1.13M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.6% 5,469 4,495 $829K
70450 Computed tomography, head or brain; without contrast material 5.5% 5,607 4,630 $813K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.2% 4,446 3,832 $774K
96361 Intravenous infusion, hydration; each additional hour 3.7% 2,391 2,140 $546K
G0378 Hospital observation service, per hour 2.6% 5,097 2,909 $391K
59025 Fetal non-stress test 2.1% 1,864 1,410 $307K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.7% 1,461 1,307 $259K
93975 1.0% 2,141 1,895 $154K
76700 Ultrasound, abdominal, real time with image documentation; complete 1.0% 1,505 1,359 $152K
144 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.0% 817 $151K
71275 Computed tomographic angiography, chest, with contrast material <1% 476 $120K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 559 $101K
76830 Ultrasound, transvaginal <1% 1,022 $89K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,287 $79K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,081 $75K
80053 Comprehensive metabolic panel <1% 23,166 $74K
70496 <1% 275 $72K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 742 $58K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,238 $57K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,076 $55K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,220 $53K
72125 Computed tomography, cervical spine; without contrast material <1% 2,006 $46K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 353 $45K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,828 $39K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 672 $39K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,588 $37K
71045 Radiologic examination, chest; single view <1% 11,032 $35K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,490 $32K
80048 Basic metabolic panel (calcium, ionized) <1% 7,129 $29K
71046 Radiologic examination, chest; 2 views <1% 2,662 $26K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,050 $25K
85027 <1% 30,172 $25K
93971 <1% 336 $24K
97163 <1% 354 $23K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 783 $19K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 577 $19K
87040 <1% 2,799 $18K
84484 <1% 9,572 $15K
86756 <1% 2,896 $15K
96375 Therapeutic injection; each additional sequential IV push <1% 6,416 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,806 $13K
83880 <1% 2,080 $12K
77063 Screening digital breast tomosynthesis, bilateral <1% 310 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 108 $9K
76857 <1% 151 $9K
81025 <1% 1,874 $7K
85379 <1% 1,793 $6K
84443 Thyroid stimulating hormone (TSH) <1% 2,195 $6K
97116 <1% 320 $5K
70498 <1% 284 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 684 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 1,430 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 103 $4K
73564 <1% 460 $4K
80076 <1% 1,195 $4K
85610 <1% 7,061 $4K
84703 <1% 6,796 $4K
36415 Collection of venous blood by venipuncture <1% 2,502 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 12,675 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 310 $3K
83690 <1% 7,774 $3K
83735 <1% 5,064 $3K
97162 <1% 137 $3K
0042T <1% 12 $3K
83605 <1% 2,339 $3K
80061 Lipid panel <1% 1,085 $3K
73030 <1% 491 $3K
74018 <1% 378 $3K
70486 <1% 116 $2K
86885 <1% 2,202 $2K
86900 <1% 3,588 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,106 $2K
76642 <1% 12 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,285 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 6,842 $2K
81001 <1% 7,895 $2K
88304 <1% 136 $2K
A9270 Non-covered item or service <1% 5,977 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,054 $2K
85730 <1% 4,426 $2K
73130 <1% 325 $2K
73630 <1% 436 $1K
86901 <1% 2,374 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,823 $1K
81003 <1% 5,230 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,660 $1K
73610 <1% 328 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,356 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,111 $945.46
84702 <1% 1,473 $898.98
87070 <1% 2,026 $889.35
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 203 $879.86
82550 <1% 1,305 $827.50
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 15 $772.44
90715 <1% 38 $755.83
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,224 $754.95
96376 <1% 652 $673.43
84439 <1% 285 $595.28
86140 <1% 392 $555.63
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,844 $393.01
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 26 $392.76
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,973 $356.77
82565 <1% 466 $264.43
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 185 $189.78
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 1,280 $177.83
82553 <1% 75 $176.10
87186 <1% 709 $174.97
97535 Self-care/home management training, each 15 minutes <1% 13 $172.12
85651 <1% 152 $124.30
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 125 $105.98
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 126 $92.65
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 900 $86.90
J2060 Injection, lorazepam, 2 mg <1% 868 $79.70
73590 <1% 16 $75.26
82150 <1% 111 $73.77
82607 <1% 20 $72.39
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 986 $68.31
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,372 $48.16
73560 <1% 21 $41.71
82248 <1% 41 $31.87
76376 <1% 260 $29.22
87077 <1% 198 $28.75
87147 <1% 30 $27.57
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 349 $22.75
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 199 $19.33
J1170 Injection, hydromorphone, up to 4 mg <1% 218 $15.59
85652 <1% 13 $13.60
J1815 Injection, insulin, per 5 units <1% 211 $12.61
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 239 $11.55
J2550 Injection, promethazine hcl, up to 50 mg <1% 76 $9.39
S0028 Injection, famotidine, 20 mg <1% 259 $8.06
84520 <1% 17 $7.11
84100 <1% 46 $6.42
J1644 Injection, heparin sodium, per 1000 units <1% 86 $6.05
J0690 Injection, cefazolin sodium, 500 mg <1% 313 $5.27
87205 <1% 16 $5.22
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 139 $4.85
J0780 Injection, prochlorperazine, up to 10 mg <1% 199 $3.00
J7050 Infusion, normal saline solution, 250 cc <1% 407 $2.84
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 332 $2.25
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 395 $0.50
J8540 Dexamethasone, oral, 0.25 mg 0% 25 $0.00
J2704 Injection, propofol, 10 mg 0% 474 $0.00
J3490 Unclassified drugs 0% 425 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 30 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 27 $0.00
C1769 Guide wire 0% 24 $0.00
73090 0% 17 $0.00
73110 0% 38 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 145 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 14 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 18 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 27 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSKEENS, HENRIETTE (CFO)